Biocon will acquire all of Viatris’ convertible preferred equity in Biocon Biologics for $400 million in cash and $415 million in newly issued Biocon shares
Roche says the move marks a step forward in its digital transformation strategy
In 2024, 59 countries reported large or disruptive measles outbreaks – nearly triple the number reported in 2021 and the highest since the onset of the COVID-19 pandemic
Soficitinib is a potent and selective TYK2 inhibitor under development for multiple T-cell mediated autoimmune disorders
Nitrosamines have prompted evolving global guidelines that demand rigorous industry oversight
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
The formulation is backed by over 80 clinical trials and 200 scientific publications
_256_384.png)
Over 700 exhibitors from APAC, Europe, the US, and beyond showcased the latest in personal care innovation
The initiative aims to connect startups and tech companies with its business units,
Subscribe To Our Newsletter & Stay Updated
